Detalhe da pesquisa
1.
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.
Future Oncol
; 16(18): 1235-1243, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32490686